Our impact on healthcare

Our technology

Dr. Shubhita Tripathi

PhD (Microbiology & Immunology), NUS Singapore

Co-Founder & CEO

Dr. Arjun Ramaswami Palaniappan

PhD (Electrical & Electronic Engineering), NTU Singapore

Co-Founder & CTO

Our technology combines the power of our unique biomarkers and state-of-the-art electronics to precisely identify multiple pathogens from a single test. A single cartridge can identify multiple pathogens from patient samples within 60 minutes at a lower cost and lower time compared with other commercially available nucleic acid tests (NAT). No specialized training is required to perform the tests. 

Meet the founders

Supported by the best

50X faster and 10X cheaper point-of-care rapid diagnostic device for early detection of infectious diseases


Rapidly detect pathogens from patients samples within 1 hour as opposed to conventional culture methods that takes 2 to 14 days and NAT techniques that takes 3 to 5 hours.


Proprietary Biomarkers


Our proprietary biomarkers achieve high sensitivity and specificity without the need for amplification

50X Faster Time to Results


50X faster than culture techniques. Our device can precisely identify pathogens present in sample and can provide data on severity of infection

No Specialized Manpower


No specialized manpower is required to perform tests. Can be used by any healthcare staff



Our device is portable and can be used in any healthcare setting like hospitals, diagnostic labs, ICUs, remote locations and clinics

10X Cheaper


The cost per test is 10X cheaper than NAT tests. 10X reduction in operating costs.

10X reduction in device cost